ABBV R&D to Revenue
AbbVie · R&D to Revenue
ABBV R&D to Revenue
Latest reported13.80%period ending
ABBV Quarterly R&D/Revenue (15.07% → 13.80%)
Latest values, visible window
High-resolution chart · PNG
ABBV r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 13.7964% | |
| 16.4778% | |
| 15.5193% | |
| 14.6995% | |
| 13.817% | |
| 15.4913% | |
| 44.855% | |
| 14.7303% | |
| 13.4698% | |
| 15.7514% | |
| 15.4465% | |
| 12.3717% | |
| 12.4991% | |
| 18.7485% | |
| 13.4449% | |
| 11.1666% | |
| 12.878% | |
| 12.1288% | |
| 14.994% | |
| 14.3843% | |
| 13.6041% | |
| 14.2352% | |
| 15.8031% | |
| 13.5715% | |
| 23.3573% | |
| 15.9995% | |
| 19.313% | |
| 26.9489% | |
| 16.7414% | |
| 18.4466% | |
| 81.8182% | |
| 16.0636% | |
| 15.97% | |
| 16.549% | |
| 22.1476% | |
| 17.5554% | |
| 17.9147% | |
| 17.4671% | |
| 18.0989% | |
| 18.4391% | |
| 18.5059% | |
| 16.0457% | |
| 16.7969% | |
| 23.856% | |
| 18.3379% | |
| 18.6111% | |
| 16.6361% | |
| 22.3152% | |
| 17.2554% | |
| 16.9187% | |
| 16.5525% | |
| 20.0515% | |
| 16.6027% | |
| 14.6454% | |
| 18.6181% | |
| 18.0346% | |
| 16.7371% | |
| 18.9792% | |
| 15.9358% | |
| 15.0957% | |
| 13.7973% | |
| 15.0663% |